Cargando…
Histological Regression of Giant Cell Tumor of Bone Following RANK Ligand Inhibition
Lung metastases are a rare complication of giant cell tumors of bone. We herein describe an interesting case of histological regression and size reduction of lung metastases originating from a primary giant cell tumor of bone in response to the RANK ligand inhibitor denosumab.
Autores principales: | Dietrich, Martin F., Cavuoti, Dominick, Landay, Michael, Arriaga, Yull E. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4528877/ https://www.ncbi.nlm.nih.gov/pubmed/26425630 http://dx.doi.org/10.1177/2324709614560216 |
Ejemplares similares
-
Robust reduced-rank regression
por: She, Y., et al.
Publicado: (2017) -
The Role of RANK-Ligand Inhibition in Cancer: The Story of Denosumab
por: Castellano, Daniel, et al.
Publicado: (2011) -
Expression of osteoprotegerin and RANK ligand in breast cancer bone metastasis.
por: Park, Hye-Rim, et al.
Publicado: (2003) -
Rank regression: an alternative regression approach for data with outliers
por: CHEN, Tian, et al.
Publicado: (2014) -
RANK and RANK ligand expression in primary human osteosarcoma
por: Branstetter, Daniel, et al.
Publicado: (2015)